A plain-language, continually updated guide from Dr. Matt Chalmers’ clinical reference on hormones and peptides.
Human chorionic gonadotropin (HCG) is a glycoprotein hormone that activates the same LH/HCG receptor used by luteinizing hormone. In men, that receptor is located on the Leydig cells of the testes. Activating it supports intratesticular testosterone production and helps maintain testicular function.
This matters during testosterone replacement therapy because external testosterone suppresses the hypothalamic-pituitary-gonadal axis, reducing the body’s own LH and FSH signals. HCG can bypass the suppressed LH signal at the testes, although it does not replace every function of FSH.
Under medical supervision, HCG may be considered when preserving testicular volume, intratesticular testosterone, fertility potential, or endogenous testicular activity is an important treatment goal.
HCG can increase both testosterone and estradiol. Monitoring may include symptoms, testosterone, estradiol, hematocrit, fertility goals, testicular response, and semen analysis when pregnancy is a goal. Active fertility planning may require additional reproductive evaluation or FSH/HMG-directed care rather than HCG alone.
More is not automatically better. Dose and frequency should be individualized from the patient’s response and laboratory findings.
HCG is a prescription medication with FDA-approved uses in specific reproductive and endocrine conditions. Use alongside testosterone therapy may be off-label and requires evaluation and supervision by an appropriately licensed medical provider. This page is educational and does not provide an individual treatment recommendation.
HCG can help maintain intratesticular testosterone and may support spermatogenesis potential, but it does not guarantee fertility. Men actively trying to conceive should receive individualized evaluation, including semen testing when appropriate.
Yes. Stimulation of the testes can increase both testosterone and estradiol, which is why symptoms and laboratory values should be monitored when HCG is started or adjusted.
Hormone decisions should be based on your goals, symptoms, laboratory findings, and medical history.
Based on The Complete Clinical Reference: Hormones, Peptides & Performance Compounds by Dr. Matt Chalmers. Medical services are provided with physician oversight from Dr. Deborah Z. Bain, MD, FAAP.
